6.58  -0.03 (-0.45%)		01-16 16:00
Open: 6.61 High: 6.77 Volume: 313,260		Pre. Close: 6.61 Low: 6.57 Market Cap: 471(M)

Short term
Mid term
Targets	6-month :	8.03	1-year :	9.38
Resists	First :	6.88	Second :	8.03
Pivot price	6.49
Supports	First :	6.38	Second :	6.07
MAs	MA(5) :	6.61	MA(20) :	6.43
	MA(100) :	7.47	MA(250) :	6.79
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	69.5	D(3) :	69.8
RSI	RSI(14): 53.1
52-week	High :	9.61	Low :	4.94

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SIGA ] has closed below upper band by 40.7%. Bollinger Bands are 24.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	6.77 - 6.82	6.82 - 6.86
Low:	6.48 - 6.53	6.53 - 6.56
Close:	6.52 - 6.59	6.59 - 6.65

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.

Fri, 16 Jan 2026
Siga Technologies Inc. (SIGA) Stock Declines While Market Improves: Some Information for Investors - sharewise.com

Thu, 15 Jan 2026
(SIGA) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Fri, 09 Jan 2026
Assessing SIGA Technologies (SIGA) Valuation As Biodefense Strength Draws Renewed Investor Attention - Sahm

Thu, 08 Jan 2026
Deep Value Biodefense Pharmaceutical Company – SIGA Technologies Inc (SIGA) - The Acquirer's Multiple

Thu, 08 Jan 2026
Siga Technologies Target of Unusually High Options Trading (NASDAQ:SIGA) - MarketBeat

Mon, 01 Dec 2025
Siga Technologies: As Market Waits For MPOXX Purchases, I Remain On The Sidelines (SIGA) - Seeking Alpha

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Shares Out	72 (M)
Shares Float	41 (M)
Held by Insiders	43.2 (%)
Held by Institutions	49.2 (%)
Shares Short	3,200 (K)
Shares Short P.Month	3,120 (K)

EPS	1.02
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	2.83
Profit Margin	43.2 %
Operating Margin	-390.2 %
Return on Assets (ttm)	26.4 %
Return on Equity (ttm)	39.9 %
Qtrly Rev. Growth	-73.9 %
Gross Profit (p.s.)	1.57
Sales Per Share	2.4
EBITDA (p.s.)	1.26
Qtrly Earnings Growth	0 %
Operating Cash Flow	117 (M)
Levered Free Cash Flow	88 (M)

PE Ratio	6.38
PEG Ratio	0
Price to Book value	2.31
Price to Sales	2.73
Price to Cash Flow	4.03

Dividend	0.6
Forward Dividend	0
Dividend Yield	9.1%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.